Pieter Pannus
5PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 24, 2023
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial.Pieter Pannus, Stéphanie Depickère, Delphine Kemlin
|Nov 07, 2022
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with Cancer.Yana Debie, Jonas R M Van Audenaerde, Timon Vandamme
|Mar 09, 2022
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.Kevin K Ariën, Leo Heyndrickx, Johan Michiels
|Sep 23, 2021
Hybrid immunity to SARS-CoV-2 in kidney transplant recipients and hemodialysis patients.Delphine Kemlin, Anne Lemy, Pieter Pannus
|Feb 29, 2020
Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on-going viral transcription.Pieter Pannus, Sofie Rutsaert, Stéphane De Wit
Pageof 1
Frequent Collaborators
2 joint publications
Delphine Kemlin
2 joint publications
Arnaud Marchant
2 joint publications
Kevin K Ariën
2 joint publications
Maria E Goossens
1 joint publications
Marie-Angélique De Scheerder
1 joint publications
Anne Lemy
1 joint publications
Isabelle Desombere
1 joint publications
Nicolas Gemander
1 joint publications
Alain Le Moine
1 joint publications
Geert A Martens
